| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/08/2010 | CN101119971B Cyclohepta[b]pyridine-3-carbonylguanidine derivative and pharmaceutical product containing same |
| 09/07/2010 | US7790916 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine |
| 09/07/2010 | US7790902 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents |
| 09/07/2010 | US7790858 Immunoadhesin comprising increased neonatal Fc receptor specificity for use in treatment and prevention of cell proliferative disorders |
| 09/07/2010 | US7790773 a cyclopentene sugar amine derivative useful as beta -galactosidase stabilizing agent |
| 09/07/2010 | US7790764 Biologically active macrolides, compositions, and uses thereof |
| 09/07/2010 | US7790750 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 09/07/2010 | US7790738 Methods of treating and preventing AIDS using of COX-2 inhibitors |
| 09/07/2010 | US7790736 Dipeptidyl peptidase inhibitors |
| 09/07/2010 | US7790725 Thiazolidine derivatives and medicinal use thereof |
| 09/07/2010 | US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes |
| 09/07/2010 | US7790716 fatty acid biosynthesis inhibitors such as E)-3-(6-aminopyridin-3-yl)-N-methyl-N-(1-methyl-1H-pyrrolo[2,3-b]pyridin-3-ylmethyl)acrylamide, used fro the treatment of bacterial infections; antibiotics |
| 09/07/2010 | US7790713 Inhibitors of interleukin-1β converting enzyme |
| 09/07/2010 | US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment |
| 09/07/2010 | US7790703 New phosphonate ester derivatives of purine or pyrimidine antivirals; side effect reduction, less toxic, bioavailability |
| 09/07/2010 | US7790692 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy |
| 09/07/2010 | US7790684 Method of inhibiting osteoclast activity |
| 09/07/2010 | US7790408 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents |
| 09/07/2010 | US7790166 Anti-CD40 antibodies capable of blocking B-cell activation |
| 09/07/2010 | US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 09/07/2010 | US7790157 Methods of modulating CARK protein activity |
| 09/07/2010 | US7789841 Method and apparatus for connective tissue treatment |
| 09/07/2010 | CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/07/2010 | CA2492081C Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 09/07/2010 | CA2454785C 4-oxoimidazolidine-2-spiropiperidine derivatives |
| 09/07/2010 | CA2438854C Method of preparing non-hydrated fexofenadine hydrochloride and novel crystalline form obtainable by this method |
| 09/07/2010 | CA2414774C Use of dopamine d2/d3 receptor agonists to treat fibromyalgia |
| 09/07/2010 | CA2375810C Beta2-adrenoceptor agonists |
| 09/07/2010 | CA2370344C Thieno- and furopyrimidine derivatives as a2a-receptor antagonists |
| 09/07/2010 | CA2368814C Use of glucosylceramide synthesis inhibitors in therapy |
| 09/07/2010 | CA2226177C Analogs of parathyroid hormone |
| 09/02/2010 | WO2010099200A1 Oligomer-amino acid conjugates |
| 09/02/2010 | WO2010098433A1 Coenzyme q10-containing composition for oral ingestion |
| 09/02/2010 | WO2010098428A1 Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst |
| 09/02/2010 | WO2010098396A1 Process for producing phenyl-substituted heterocyclic derivative |
| 09/02/2010 | WO2010098367A1 Pyrimidopyrimidoindazole derivative |
| 09/02/2010 | WO2010098365A1 Nucleoside-type antibiotic |
| 09/02/2010 | WO2010098286A1 Pharmaceutical preparation containing mineralcorticoid receptor antagonist |
| 09/02/2010 | WO2010098265A1 Polymeric micelle containing proteasome inhibitor |
| 09/02/2010 | WO2010098261A1 Risperidone-containing transdermal preparation and adhesive patch using same |
| 09/02/2010 | WO2010098230A1 Transdermal preparation |
| 09/02/2010 | WO2010098166A1 Cell adhesion inhibitor and use thereof |
| 09/02/2010 | WO2010098145A1 Oxyindole derivatives with motilin receptor agonistic activity |
| 09/02/2010 | WO2010098125A1 Retinoid x receptor partial agonist compound |
| 09/02/2010 | WO2010053606A9 Small-molecule inhibitors of protein synthesis inactivating toxins |
| 09/02/2010 | US20100223681 Assessment Method |
| 09/02/2010 | US20100222875 Method for forming a porous stent coating |
| 09/02/2010 | US20100222867 Drug delivery from stents |
| 09/02/2010 | US20100222555 Monoclonal antibodies that neutralize botulinum neurotoxin |
| 09/02/2010 | US20100222439 Beverage containing a polymeric polyphenol |
| 09/02/2010 | US20100222414 SiRNA Sequence-Independent Modification Formats for Reducing Off-Target Phenotypic Effects in RNAi, and Stabilized Forms Thereof |
| 09/02/2010 | US20100222407 Triblock copolymers for cytoplasmic delivery of gene-based drugs |
| 09/02/2010 | US20100222405 Magnesium salts of hmg-coa reductase inhibitors |
| 09/02/2010 | US20100222386 Substituted piperidines |
| 09/02/2010 | US20100222362 N-oxides of n-phenyl-2-pyramidine-amine derivatives |
| 09/02/2010 | US20100222361 2-acylaminothiazole derivative or salt thereof |
| 09/02/2010 | US20100222330 New Compounds |
| 09/02/2010 | US20100222329 2-acylaminothiazole derivative or salt thereof |
| 09/02/2010 | US20100222305 Complexes of phosphate derivatives |
| 09/02/2010 | US20100222285 Method of controlling the proliferation of vascular endothelial cells and inhibiting lumen formation |
| 09/02/2010 | US20100222284 Composition for inhibiting the onset of arteriosclerosis and inhibition method |
| 09/02/2010 | US20100222274 Glycosylation-deficient hepatocyte growth factor |
| 09/02/2010 | US20100221766 NUCLEAR TRANSFER PROMOTER FOR Cdc42 PROTEIN AND METHOD OF SCREENING THE SAME |
| 09/02/2010 | US20100221746 Compositions and methods for the treatment of disease |
| 09/02/2010 | US20100221348 Therapeutic uses of dunaliella powder |
| 09/02/2010 | US20100221346 Method For Transfecting Cells Using A Magnetic Field |
| 09/02/2010 | US20100221333 Pellets Comprising a Core With a Water-Soluble Carrier |
| 09/02/2010 | US20100221332 Methodology and apparatus for oral dual delivery of homeopathic products and non-homeopathic products |
| 09/02/2010 | US20100221312 Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering |
| 09/02/2010 | US20100221311 Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering |
| 09/02/2010 | US20100221303 Method for Preparing Porous Scaffold for Tissue Engineering, Cell Culture and Cell Delivery |
| 09/02/2010 | US20100221299 Therapeutic stem cell nutrient composition and uses thereof |
| 09/02/2010 | US20100221297 Method of producing emulsion or dispersion and food, skin external preparation and drug containing emulsion or dispersion obtained by the production method |
| 09/02/2010 | US20100221259 Nitrogen-containing heterocyclic compounds and medicinal use thereof |
| 09/02/2010 | US20100221235 Compositions and Methods for Treating Lysosomal Storage Diseases |
| 09/02/2010 | US20100221230 Elective Collection and Banking of Autologous Peripheral Blood Stem Cells |
| 09/02/2010 | US20100221224 Composition and method for self-assembly and mineralization of peptide-amphiphiles |
| 09/02/2010 | US20100221190 Method for producing a particle comprising a gas core and a shell and particles thus obtained |
| 09/02/2010 | CA2753426A1 Coenzyme q10-containing composition for oral ingestion |
| 09/02/2010 | CA2752485A1 Process for producing phenyl-substituted heterocyclic derivative through coupling using transition metal catalyst |
| 09/02/2010 | CA2750716A1 Pyrimidopyrimidoindazole derivative |
| 09/02/2010 | CA2750699A1 Oxyindole derivatives with motilin receptor agonistic activity |
| 09/01/2010 | EP2224010A1 Improved gene expression |
| 09/01/2010 | EP2223932A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 09/01/2010 | EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/01/2010 | EP2223920A2 Substituted azabicyclic compounds |
| 09/01/2010 | EP2223690A1 Pharmaceutical composition for ameliorating lower urinary tract symptom |
| 09/01/2010 | EP2223688A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof |
| 09/01/2010 | EP2223687A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof |
| 09/01/2010 | EP2222287A2 Multitarget compounds active at a ppar and cannabinoid receptor |
| 09/01/2010 | EP2010551B1 Improved treatment of cystic fibrosis |
| 09/01/2010 | EP1814857B1 Isotopically marked quinoline derivatives as adenosin a3 receptor ligands |
| 09/01/2010 | EP1726587B1 Benzothiazin-3-one compound and intermediate therefor |
| 09/01/2010 | EP1669367B1 Peptides which can bind to transforming growth factor beta 1 (tgf-beta1) |
| 09/01/2010 | EP1430027B1 Novel aminoazetidine, -pyrrolidine and -piperidine derivatives |
| 09/01/2010 | EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 09/01/2010 | EP1408117B1 Glycoprotein and process for producing the same |
| 09/01/2010 | EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 09/01/2010 | CN1938018B Use of compounds for the preparation of a therapeutical composition for treatment of various disease states associated with a reduced igf-1 serum level |
| 09/01/2010 | CN1799382B Method for preparing yin-nourishing health-preserving milk liquor with oligosaccharide and micron powder of American ginseng, dried solomonseal, tortoise plastron, dendrobium stem and siberian solomon |